Dr. Mazen Albeldawi

Dr. Mazen Albeldawi is a distinguished Gastroenterologist and Hepatologist currently serving patients at Meliora Healthcare. He has been in practice between 11-20 years and is a Fellow of the American College of Gastroenterology. His specific areas of clinical interest encompass a broad range of conditions, including colon cancer screening, GERD, celiac disease, irritable bowel syndrome, ulcerative colitis, Crohn's disease, peptic ulcers, diverticulitis, hemorrhoids, fatty liver, obesity, and swallowing disorders.

Dr. Albeldawi earned his medical degree at Ross University in New Jersey and completed his residency training in Internal Medicine at the prestigious Cleveland Clinic, further honing his expertise through a Gastroenterology and Hepatology fellowship. To enhance his proficiency in endoscopic bariatric procedures, Dr. Albeldawi sought additional training at the renowned Harvard Brigham and Women's Hospital. He holds advanced certifications from the American Board of Internal Medicine in both Gastroenterology and Hepatology.

For nearly a decade, Dr. Albeldawi served as the Head of Gastroenterology at NCH Healthcare, where his leadership left an indelible mark, and he also assumed the pivotal role of Director of Endoscopy during his tenure. He has +20 publications with over 350 citations. Dr. Albeldawi serves as a Clinical Associate Professor at the Orlando College of Osteopathic Medicine and holds the position of Associate Professor of Internal Medicine at the University of Central Florida College of Medicine.

Dr. Albeldawi has received recognition including being named a Naples Top Doctor from 2018 to 2023 and a Castle Connolly Top Doctor in 2022. As Gastroenterologist at Meliora Healthcare, Dr. Albeldawi could bring to the organization his extensive clinical expertise in complex GI conditions, established academic relationships, track record of clinical leadership, and peer-recognized standing in the gastroenterology specialty—positioning him to enhance the practice's clinical reputation and patient outcomes in digestive and hepatic disease management.